These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 35729567)

  • 1. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
    Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
    World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VDAC1 Conversely Correlates with Cytc Expression and Predicts Poor Prognosis in Human Breast Cancer Patients.
    Chen F; Yin S; Luo B; Wu X; Yan H; Yan D; Chen C; Guan F; Yuan J
    Oxid Med Cell Longev; 2021; 2021():7647139. PubMed ID: 33680287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling of mitochondrial voltage-dependent anion channel-1 associated genes predicts recurrence-free survival in human carcinomas.
    Ko JH; Gu W; Lim I; Zhou T; Bang H
    PLoS One; 2014; 9(10):e110094. PubMed ID: 25333947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel immune-related prognostic index for predicting breast cancer overall survival.
    Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
    Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinical significance of CLDN7 and its immune-related cells in breast cancer.
    Fan X; Qi A; Zhang M; Jia Y; Li S; Han D; Liu Y
    Diagn Pathol; 2024 Aug; 19(1):113. PubMed ID: 39175074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation.
    Zhao W; Chang Y; Wu Z; Jiang X; Li Y; Xie R; Fu D; Sun C; Gao J
    PeerJ; 2023; 11():e15703. PubMed ID: 37483962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
    Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
    Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prognostic biomarkers of breast cancer based on the immune-related gene module.
    Wang R; Zeng H; Xiao X; Zheng J; Ke N; Xie W; Lin Q; Zhang H
    Autoimmunity; 2023 Dec; 56(1):2244695. PubMed ID: 37584152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.
    Xu N; Meng X; Chu H; Yang Z; Jiao Y; Li Y
    PeerJ; 2023; 11():e15654. PubMed ID: 37520246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.
    Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D
    BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models.
    Fang Y; Zhang Q; Guo C; Zheng R; Liu B; Zhang Y; Wu J
    Front Immunol; 2024; 15():1461489. PubMed ID: 39380996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder Cancer.
    Alhozeel B; Pandey SK; Shteinfer-Kuzmine A; Santhanam M; Shoshan-Barmatz V
    Cells; 2024 Apr; 13(7):. PubMed ID: 38607066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients.
    Meng X; Wang L; He M; Yang Z; Jiao Y; Hu Y; Wang K
    PLoS One; 2022; 17(6):e0269998. PubMed ID: 35771747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
    Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
    World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis.
    Wu Z; Wan J; Wang J; Meng X; Qian H
    Biochem Biophys Rep; 2022 Mar; 29():101203. PubMed ID: 35059509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.
    He M; Hu C; Deng J; Ji H; Tian W
    World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
    Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
    Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer.
    Liu J; Ling Y; Su N; Li Y; Tian S; Hou B; Luo S; Zhao L; Shi M
    Transl Cancer Res; 2022 Jan; 11(1):181-192. PubMed ID: 35261895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.